Dr. Anirban Dutta visited Amrita Vishwa Vidyapeetham and gave a talk on "A Portable Brain Scanner with Telemonitoring Platform", on January 12, 2018.
Of the Three million neonatal deaths globally in 2012, 779,000 took place in India
In India, hypoxic-ischemic encephalopathy (HIE), brain injury caused by oxygen deprivation to the brain, contributes to 20% of neonatal mortality and 50% of early neonatal mortality - 400 children losing their lives daily in India to HIE alone.
Neonatal Mortality Rate (NMR) is disproportionately high in the rural area and among poor and hard to reach, vulnerable population.
As NMR is a major healthcare delivery indicator, this reveals a uniquely vulnerable group who can benefit from improved physiology-based treatment during HIE at remote point-of-care for "intact survival." But currently, no affordable point-of-care technology exists to detect, monitor and manage HIE.
Structural imaging (CT/ MRI/ Ultrasound) is far and few in India and healthcare resources, such as radiologists, neonatologists are scarce.
This two-fold scarcity of technology and workforce causes "delayed detection and intervention” resulting in high mortality in HIE among neonates, especially in rural India.
Hence providing an affordable brain monitoring system allowing early identification and management of HIE at point-of-care by community health workers (CHW), such as an Accredited Social Health Activist (ASHA) or ANM (Auxiliary Nurse Midwifery) will be a paradigm-shift in neonatal care.
Dr. Anirban Dutta is an Assistant Professor of Biomedical Engineering, Biomedical Engineering, University at Buffalo, the State University of New York.
As director of UB’s Neuroengineering and Informatics for Rehabilitation Laboratory (NIRlab), he conducts interdisciplinary research in neural engineering, the application of engineering to the neurosciences. His academic and research training in neurotechnology, motor rehabilitation, clinical neurophysiology and cerebrovascular medicine provides him with the expertise for translational research focused on developing computational models and hardware technologies for neural interfaces to monitor and activate beneficial neural function.
Dr. Anirban Dutta’s research transcends conventional academic boundaries in his overarching goal to treat, cure and even prevent neurological disorders using ‘electroceuticals’ -- bioelectronics that stimulate the nervous system. Specifically, his research is directed toward an enhanced understanding of the neurophysiological mechanisms associated with the re-learning of visomotor function. His special focus on neurorehabilitation uses neuroengineering and informatics to leverage human-machine interfaces.